Skip to main content
. 2001 May;8(3):598–603. doi: 10.1128/CDLI.8.3.598-603.2001

TABLE 2.

MAb reactivities with C-terminal mutants of the PRRSV N protein

MAb Fig. 2 panel Reactivitya with
Reference
PA8 Nb Rec Nc C-11d V112P R113P R113D L114P I115P R116P T118S P121A
ISU15A A + + + + + + + + + + + 28
ISU15B B + + + + + 28
ISU15C C + + + + 28
ISU15E D + + + + 28
K9-5 D + + + + 29
MR40 D + + + + 20
K9-3 E + + + 29
ISU15Fd-11 F + + + + + 29
ISU15Fd-32 G + + +/− +/− +/− + 29
ISU15Fd H + + +/− +/− + 29
SDOW17 I + + +/− +/− +/− +/− + 19
K9-9 I + + +/− +/− +/− +/− + 29
SR30 J + + + + +/− + 20
VO17 K + + + + + + + 19
JP25 L + + + + + + 20
EP147 M + + + 19
1D2 M + + + D. Deregte
7C10 M + + + D. Deregt
2D6 N + + + + +/− D. Deregt
2G7 N + + + + +/− D. Deregt
a

+, positive (N protein detected after 48 h of exposure); +/−, weakly positive (N protein detected after 1 week of exposure); −, negative (N protein undetectable after 1 week of exposure). 

b

Authentic N protein from PRRSV-infected cell lysates. 

c

Recombinant N protein expressed from vaccinia virus. 

d

N protein with a deletion of the 11 C-terminal-most amino acids. 

e

Animal Disease Research Institute.